1. Home
  2. IPW vs RLYB Comparison

IPW vs RLYB Comparison

Compare IPW & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

HOLD

Current Price

$1.24

Market Cap

1.8M

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$8.09

Market Cap

44.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPW
RLYB
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
44.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IPW
RLYB
Price
$1.24
$8.09
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
184.4K
96.8K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,142,779.00
$858,000.00
Revenue This Year
$149.67
N/A
Revenue Next Year
$15.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.00
52 Week Low
$0.43
$0.23
52 Week High
$29.10
$11.49

Technical Indicators

Market Signals
Indicator
IPW
RLYB
Relative Strength Index (RSI) 28.39 49.20
Support Level $0.50 $7.90
Resistance Level $2.79 $11.49
Average True Range (ATR) 0.16 0.57
MACD 0.06 -0.31
Stochastic Oscillator 3.94 10.82

Price Performance

Historical Comparison
IPW
RLYB

About IPW iPower Inc.

iPower Inc is a United States-based online retailer and supplier of consumer home, pet, garden, outdoor, and consumer electronics products. It also operates as a provider of value-added ecommerce services for third-party products and brands. The company's capabilities include a spectrum of online channels, fulfillment capacity, a network of warehouses serving the U.S., last-mile delivery partners, and a differentiated business intelligence platform. The company's sales channels currently include Amazon Vendor, Amazon 3P, Walmart.com, TikTok, Temu, and other marketplaces, as well as its own e-commerce websites, such as simpledeluxe.com and more. Additionally, it is developing in-house branded products and through supply chain partners, which include iPower, Simple Deluxe, and other brands.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: